IP Library Granted Patent US 10,087,432
Granted Patent B2
US 10,087,432 · App. 14/423,222 · Granted Oct 2, 2018

Methods for the manufacture of proteolytically processed polypeptides

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,087,432
App. No.
14/423,222
Granted
Oct 2, 2018
Kind
B2
Abstract

The present invention relates to a novel proteolytically active polypeptide and various uses of the polypeptide (and others) in screening and manufacturing methods.

Claims (8)

1. A method for manufacturing a di-chain botulinum neurotoxin serotype A (BoNT/A) or derivative thereof, the method comprising contacting a Lys-C polypeptide with a single-chain BoNT/A or derivative thereof;

wherein the single-chain BoNT/A or derivative thereof is proteolytically processed by the Lys-C polypeptide to produce the di-chain BoNT/A or derivative thereof.

2. The method of claim 1 , wherein the single-chain BoNT/A or derivative thereof is a naturally-occurring neurotoxin, a recombinant neurotoxin, a modified neurotoxin, a neurotoxin lacking the native H C domain or parts thereof, or a BoNT/A derivative with other amino acid residues replacing the neurotoxin H C domain.

3. The method of claim 2 , wherein the single-chain BoNT/A or derivative thereof comprises an amino acid sequence having at least 50% sequence identity with a polypeptide sequence selected from any one of SEQ ID NOs: 3 to 10.

4. The method of claim 1 , wherein the C-terminus of the L-chain and the N-terminus of the H-chain of the di-chain BoNT/A or derivative thereof are identical to the corresponding C-terminus of the L-chain and the N-terminus of the H-chain of di-chain BoNT/A isolated from wild-type clostridia.

5. The method of claim 1 , wherein the di-chain BoNT/A or derivative thereof has an identical amino acid sequence as the corresponding di-chain BoNT/A generated from the same single-chain BoNT/A polypeptide in wild-type clostridia.

6. The method of claim 1 , wherein the step of contacting the Lys-C polypeptide and the single-chain BoNT/A or derivative thereof occurs within a cell, in a cell lysate, in a purified cell lysate, or in a subject.

7. The method of claim 3 , wherein the Lys-C polypeptide proteolytically cleaves the single-chain BoNT/A or derivative thereof at a position immediately C-terminal to a basic amino acid residue within the sequence of any one of SEQ ID NOs: 3 to 10.

Assignments (3)
CHANGE OF NAME AND ADDRESS Recorded May 15, 2017
From: SYNTAXIN LIMITED
To: IPSEN BIOINNOVATION LIMITED
Reel/Frame 042458/0982 →
CHANGE OF NAME Recorded May 10, 2017
From: SYNTAXIN LIMITED
To: IPSEN BIOINNOVATION LIMITED
Reel/Frame 042522/0725 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 10, 2015
From: RUMMEL, ANDREAS
To: SYNTAXIN LIMITED
Reel/Frame 035382/0448 →
Cited By (1)
US 12,409,211